Windtree Therapeutics Profit Margin 2006-2021 | WINT
Current and historical gross margin, operating margin and net profit margin for Windtree Therapeutics (WINT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Windtree Therapeutics net profit margin as of June 30, 2021 is 0%.
|Windtree Therapeutics Annual Profit Margins
|Windtree Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.